In addition, transwell assays showed that BC cells co-transfected with PRSS22 and ANXA1 exhibited stronger migration and invasion ability than those transfected with only PRSS22 or ANXA1 (Fig. 4K, L). Here, PRSS22 is linked to breast cancer.